Our Blog

Biogen FDA Accelerated Approval Under Investigation

  By Rigby Sampson On Friday 9th July, Janet Woodcock the Acting Commissioner of the FDA (and former Director of the Centre for Drug Evaluation and Research […]

Minimum

  Pollution and the brain   Re:Cognition Health applaud new Fintech start up Minimum.eco dedicated to making carbon neutrality easily accessible to all businesses. Minimum enables businesses to calculate and offset the carbon footprint of its […]

Proactive Measures To Protect Against Dementia

Dr Emer MacSweeney was featured in the Daily Mail, exploring some of the proactive measures we can take to help protect against dementia. At Re:Cognition Health, we […]

The negative effects of working long hours

The negative effects of working long hours   According to a recent global study, 745,000 people died in the past 12 months, from heart disease or stroke […]

IS ADHD Over-Diagnosed in Children and Adolescents?

IS ADHD Over-Diagnosed in Children and Adolescents?   A recent study published in JAMA (Journal of the American Medical Association)  Network has revealed that Attention Deficit Hyperactivity […]

Aducanumab, what this means for the UK

Aducanumab, what this means for the UK        On Monday 7th June 2021 the USA approved the first medication, ever, to combat the underlying cause of Alzheimer’s Disease. Aducanumab, […]

Aducanumab receives FDA Approval

First Alzheimer’s treatment to slow disease progression receives FDA approval on 07 June 2021   Aducanumab, the first disease modifying treatment for Alzheimer’s disease, which was tested […]

Free Alzheimer’s Webinar Hosted by Re:Cognition Health

Free Alzheimer’s Webinar Hosted by Re:Cognition Health   Leading brain and mind clinic Re:Cognition Health is urging people to understand the early symptoms of Alzheimer’s disease. An […]

Understanding the Early Symptoms of MCI and Alzheimer’s Disease 

Understanding the Early Symptoms of MCI and Alzheimer’s Disease    Do you recognise  10 early symptoms of cognitive impairment which may lead to dementia? Most people think […]

Dr MacSweeney named in ScaleUp Female Founders Index

  Re:Cognition Health is delighted to announce that CEO and Founder Dr Emer MacSweeney was named in the ScaleUp Female Founders Index 2021. The list honours UK […]